newsfilter
← Latest News
GlobeNewswire·

Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility

GAITHERSBURG, Md., April 16, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company has closed on a new credit facility agreement with OrbiMed for a new $150 million term loan.